Brett Miller
MOHS-Micrographic Surgery · Doylestown, PANPI 1376802884
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 29.7% of the total.
Across 130 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$795
- Regeneron Healthcare Solutions, Inc.$314
- Incyte Corporation$217
- Johnson & Johnson$205
- Novartis$153
- Amgen$120
- plus $874 from 22 others
What the payments were for
- Food & beverage$2,678100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $795 |
| Regeneron Healthcare Solutions, Inc. | 13 | $314 |
| Incyte Corporation | 9 | $217 |
| Johnson & Johnson | 10 | $205 |
| Novartis | 6 | $153 |
| Amgen | 4 | $120 |
| LEO Pharma Inc. | 6 | $114 |
| Sanofi | 4 | $73 |
| Misonix Inc | 2 | $72 |
| Lilly USA, LLC | 4 | $71 |
| Prugen, Inc. Pharmaceuticals | 1 | $58 |
| UCB, Inc. | 2 | $57 |
| Lifenet Health | 1 | $44 |
| Boehringer Ingelheim | 2 | $43 |
| Sun Pharmaceutical Industries Inc. | 2 | $37 |
| Strata Skin Sciences, Inc. | 2 | $36 |
| Triad Life Sciences Inc. | 1 | $31 |
| Biofrontera Inc. | 3 | $30 |
| Kerecis Limited | 1 | $28 |
| Mimedx Group, Inc. | 1 | $27 |
| Bristol Myers Squibb | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| Dermira, Inc. | 1 | $22 |
| Conmed Corporation | 1 | $20 |
| Pfizer | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Organogenesis Inc. | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $11 |
How this compares
$2,678 in reported general payments places this provider in the 60th percentile of 48 mohs-micrographic surgery providers in Pennsylvania.
See all mohs-micrographic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 244 | $1,695 |
| Doxycycline Hyclate | 105 | $632 |
| Gentamicin Sulfate | 13 | $344 |
| Mupirocin | 38 | $179 |
| Triamcinolone Acetonide | 12 | $176 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $81 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Doylestown
- Robert WillardDoylestown$4K
- Gregory FulchieroAltoona$24K
- Jason SchoenfeldPhiladelphia$20K
- Cynthia BartusAllentown$10K
- Ernest BenedettoPhiladelphia$9K
- Carmen CampanelliYardley$8K
- Aradhna SaxenaFort Washington$8K
- Nicole VelezCranberry Township$6K
- Justin VujevichPittsburgh$6K
- Preetha AgarwalPittsburgh$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.